Melsmon, 2 ml 10 pcs

The principle of Melsmon action is not fully understood, but it has been reliably established that the human placenta hydrolysate contains biologically active substances that have antioxidant effect, increase the activity of tissue and cellular respiration, have a positive effect on metabolic processes in cells, stimulate tissue regeneration.

Indications

According to the instructions, Melsmon is prescribed as part of the treatment of women in the peri- and post-menopause for the correction of asthenic conditions, accompanied by excessive reactivity and excitability, decreased performance and attention.

Interaction

Melsmon can be used as part of a complex treatment with other medicines for the treatment of conditions typical of peri- and post-menopause.

Directions for use

The drug Melsmon is intended exclusively for subcutaneous administration.

Special Instructions

The drug does not contain biological stimulants – enzymes, hormones, proteins, growth factors.

Contraindications

Arterial hypertension; endocrine disorders; childhood; pregnancy and lactation; hypersensitivity to any component of Melsmon.

Side effects

Local reactions in the area of drug administration: a feeling of warmth, redness, pain; allergic reactions: chills, fever, urticaria, itching, rash, allergic dermatitis; other: nausea, pain in the breast.

Overdose

No cases of overdose have been reported.

Pregnancy use

Pregnancy and breastfeeding are contraindications to the use of Melsmon.